Armata Pharmaceuticals (ARMP) Net Income towards Common Stockholders Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.80% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -3.84% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 34.98% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 47.10% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -116.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.75% |
| Dec 31, 2025 | -21.84% |
| Sep 30, 2025 | -12.06% |
| Jun 30, 2025 | -20.93% |
| Mar 31, 2025 | -10.17% |
| Dec 31, 2024 | -31.72% |
| Sep 30, 2024 | -27.31% |
| Jun 30, 2024 | -32.51% |
| Mar 31, 2024 | -65.75% |
| Dec 31, 2023 | -18.71% |
| Sep 30, 2023 | -25.73% |
| Jun 30, 2023 | -26.71% |
| Mar 31, 2023 | -30.66% |
| Dec 31, 2022 | -31.02% |
| Sep 30, 2022 | -7.39% |
| Jun 30, 2022 | -29.95% |
| Mar 31, 2022 | -34.36% |
| Dec 31, 2021 | 12.13% |
| Sep 30, 2021 | -55.73% |
| Jun 30, 2021 | -26.64% |
| Mar 31, 2021 | -20.58% |
| Dec 31, 2020 | -41.15% |
| Sep 30, 2020 | -94.92% |
| Jun 30, 2020 | 16.33% |
| Mar 31, 2020 | -16.09% |
| Dec 31, 2019 | 21.55% |
| Sep 30, 2019 | -24.67% |
| Jun 30, 2019 | 12.88% |
| Mar 31, 2019 | 9.23% |
| Dec 31, 2018 | -40.99% |
| Sep 30, 2018 | 1.91% |
| Jun 30, 2018 | -32.78% |
| Mar 31, 2018 | 40.44% |
| Dec 31, 2017 | -32.84% |
| Sep 30, 2017 | -27.11% |
| Jun 30, 2017 | -41.89% |
| Mar 31, 2017 | 34.63% |
| Dec 31, 2016 | -251.65% |
| Sep 30, 2016 | 58.17% |
| Jun 30, 2016 | 24.49% |